Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models. Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231 - Prostate 2003;54(4):249-257

Author： Bosland M.  

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.5, 2003-09, pp. : 414-415

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial. Carducci MA, Padley RJ, Breul J, Vogelzang NJ, Zonnenberg BA, Daliani DD, Schulman CC, Nabulsi AA, Humerickhouse RA, Weinberg MA, Schmitt JL, Nelson JB, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD - J Clin Oncol 2003;21:679-689

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 410-411

Elsevier

Access to resources Recommend Favorite

Commentary on the next two abstracts follows the second abstract. Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan. Nelson JB, Nabulsi AA, Vogelzang NJ, Breul J, Zonnenberg BA, Daliani DD, Schulman CC, Carducci MA, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD - J Urol 2003;169:1143-1149

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 410-410

Elsevier

Access to resources Recommend Favorite

The evolving role of docetaxel in the management of androgen independent prostate cancer - Khan MA, Carducci MA, Partin AW, Urological Institute, Johns Hopkins Hospital, Baltimore, MD. Journal of Urology 2003;170:1709-1716

By Chatta G.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 489-490

Elsevier

Access to resources Recommend Favorite

Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status

By Bonkhoff H.  

Annals of Oncology, Vol. 12, Iss. 2, 2001-02 ,pp. : 141-144

Springer Publishing Company

Access to resources Recommend Favorite

Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 58-66

Spandidos Publications

Access to resources Recommend Favorite